157 related articles for article (PubMed ID: 38600622)
1. Epigenetic/circadian clocks and PCOS.
Vatier C; Christin-Maitre S
Hum Reprod; 2024 Jun; 39(6):1167-1175. PubMed ID: 38600622
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation in the pathogenesis of polycystic ovary syndrome.
Vázquez-Martínez ER; Gómez-Viais YI; García-Gómez E; Reyes-Mayoral C; Reyes-Muñoz E; Camacho-Arroyo I; Cerbón M
Reproduction; 2019 Jul; 158(1):R27-R40. PubMed ID: 30959484
[TBL] [Abstract][Full Text] [Related]
3. Polycystic Ovary Syndrome: the Epigenetics Behind the Disease.
Eiras MC; Pinheiro DP; Romcy KAM; Ferriani RA; Reis RMD; Furtado CLM
Reprod Sci; 2022 Mar; 29(3):680-694. PubMed ID: 33826098
[TBL] [Abstract][Full Text] [Related]
4. Derailed peripheral circadian genes in polycystic ovary syndrome patients alters peripheral conversion of androgens synthesis.
Johnson BS; Krishna MB; Padmanabhan RA; Pillai SM; Jayakrishnan K; Laloraya M
Hum Reprod; 2022 Jul; 37(8):1835-1855. PubMed ID: 35728080
[TBL] [Abstract][Full Text] [Related]
5. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells.
Qu F; Wang FF; Yin R; Ding GL; El-Prince M; Gao Q; Shi BW; Pan HH; Huang YT; Jin M; Leung PC; Sheng JZ; Huang HF
J Mol Med (Berl); 2012 Aug; 90(8):911-23. PubMed ID: 22349439
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges.
Liu YN; Qin Y; Wu B; Peng H; Li M; Luo H; Liu LL
Reprod Toxicol; 2022 Aug; 111():11-19. PubMed ID: 35562068
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell.
Xu J; Bao X; Peng Z; Wang L; Du L; Niu W; Sun Y
Oncotarget; 2016 May; 7(19):27899-909. PubMed ID: 27056885
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process.
Mimouni NEH; Paiva I; Barbotin AL; Timzoura FE; Plassard D; Le Gras S; Ternier G; Pigny P; Catteau-Jonard S; Simon V; Prevot V; Boutillier AL; Giacobini P
Cell Metab; 2021 Mar; 33(3):513-530.e8. PubMed ID: 33539777
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Reprogramming of Immune Cells in Women With PCOS Impact Genes Controlling Reproductive Function.
Hiam D; Simar D; Laker R; Altıntaş A; Gibson-Helm M; Fletcher E; Moreno-Asso A; Trewin AJ; Barres R; Stepto NK
J Clin Endocrinol Metab; 2019 Dec; 104(12):6155-6170. PubMed ID: 31390009
[TBL] [Abstract][Full Text] [Related]
10. [Epigenetics of polycystic ovary syndrome].
Concha C F; Sir P T; Recabarren SE; Pérez B F
Rev Med Chil; 2017 Jul; 145(7):907-915. PubMed ID: 29182200
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis.
Pan JX; Tan YJ; Wang FF; Hou NN; Xiang YQ; Zhang JY; Liu Y; Qu F; Meng Q; Xu J; Sheng JZ; Huang HF
Clin Epigenetics; 2018; 10():6. PubMed ID: 29344314
[TBL] [Abstract][Full Text] [Related]
12. Androgen-mediated Perturbation of the Hepatic Circadian System Through Epigenetic Modulation Promotes NAFLD in PCOS Mice.
Roy S; Abudu A; Salinas I; Sinha N; Cline-Fedewa H; Yaw AM; Qi W; Lydic TA; Takahashi DL; Hennebold JD; Hoffmann HM; Wang J; Sen A
Endocrinology; 2022 Oct; 163(10):. PubMed ID: 35933634
[TBL] [Abstract][Full Text] [Related]
13. DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome.
Sagvekar P; Kumar P; Mangoli V; Desai S; Mukherjee S
Clin Epigenetics; 2019 Apr; 11(1):61. PubMed ID: 30975191
[TBL] [Abstract][Full Text] [Related]
14. Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome.
Wang P; Zhao H; Li T; Zhang W; Wu K; Li M; Bian Y; Liu H; Ning Y; Li G; Chen ZJ
Endocrinology; 2014 Apr; 155(4):1445-52. PubMed ID: 24527662
[TBL] [Abstract][Full Text] [Related]
15. Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome.
Li S; Zhai J; Chu W; Geng X; Chen ZJ; Du Y
Transl Res; 2020 May; 219():13-29. PubMed ID: 32119846
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial epigenetic modifications and nuclear-mitochondrial communication: A new dimension towards understanding and attenuating the pathogenesis in women with PCOS.
Shukla P; Melkani GC
Rev Endocr Metab Disord; 2023 Apr; 24(2):317-326. PubMed ID: 36705802
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Marks in Polycystic Ovary Syndrome.
Motta AB
Curr Med Chem; 2020; 27(39):6727-6743. PubMed ID: 31580245
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment.
Stener-Victorin E; Deng Q
Nat Rev Endocrinol; 2021 Sep; 17(9):521-533. PubMed ID: 34234312
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome.
Nilsson E; Benrick A; Kokosar M; Krook A; Lindgren E; Källman T; Martis MM; Højlund K; Ling C; Stener-Victorin E
J Clin Endocrinol Metab; 2018 Dec; 103(12):4465-4477. PubMed ID: 30113663
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome.
Yu YY; Sun CX; Liu YK; Li Y; Wang L; Zhang W
Fertil Steril; 2015 Jul; 104(1):145-53.e6. PubMed ID: 25956362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
